Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Asahi Kasei Medical, Kuraray Medical to Merge Dialysis Business First
July 23, 2007
- Increases in DPC Hospitals Drive Nichi-Iko's Business
July 23, 2007
- MEDICAL DEVICE NEWS IN BRIEF
July 23, 2007
- Nippon Chemiphar to Drastically Shift Priority to Generics
July 23, 2007
- Number of Patients Enrolled in Avastin PMS Exceeds 500 in 1 Month: Chugai
July 23, 2007
- BUSINESS NEWS IN BRIEF
July 23, 2007
- 7 Drugs Transiently Excluded from DPC
July 23, 2007
- Excessive Thoroughness Should Be Eliminated in Source Data Verification: Seminar
July 23, 2007
- Hospital Stay Shortens but Readmission Rate Rises under the Current DPC System
July 23, 2007
- Korosho Calls on Pharmacists to Actively Participate in Anticancer Chemotherapy
July 23, 2007
- MCH to Search Cerebral Infarction Biomarkers with Kyushu Univ.
July 23, 2007
- Evista to Reach \20 Bil. Sales Goal Ahead of Schedule
July 23, 2007
- Comtan Stabilizes Levodopa Concentrations: Novartis Seminar
July 23, 2007
- MTPC Aims to Successively Launch Global Products, Stably Supply High-Quality Essential Drugs: Mr Hayama
July 23, 2007
- Number of Candidate Compounds Show Promise for NSCLC: Pfizer
July 23, 2007
- Daiichi Sankyo Obtains License on Denosumab from Amgen
July 23, 2007
- Otsuka, GW Pharmaceuticals Sign Joint Research Agreement
July 23, 2007
- Wyeth Japan Committed to Catching Up with the Rest of the World
July 23, 2007
- REGULATORY NEWS IN BRIEF
July 23, 2007
- Price Agreement Rate Rose to 92.4% as of End of March
July 23, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…